1h
HealthDay on MSNOzempic, Wegovy Linked To Potential Vision LossPeople taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye co ...
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.
4d
Medpage Today on MSNSemaglutide Tied to Small Risk of Potentially Blinding Eye ConditionThe use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
4h
Hosted on MSNHims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide UpdateHims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results